A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework
暂无分享,去创建一个
Xiaoming Li | Peter B. Gilbert | Xiaopeng Miao | Ivan S. F. Chan | P. Gilbert | I. Chan | Xiaopeng Miao | Xiaoming Li
[1] Tyler J VanderWeele,et al. Principal Stratification -- Uses and Limitations , 2011, The international journal of biostatistics.
[2] D. Rubin. Multiple imputation for nonresponse in surveys , 1989 .
[3] B. Graubard,et al. Statistical validation of intermediate endpoints for chronic diseases. , 1992, Statistics in medicine.
[4] J. Pearl. The International Journal of Biostatistics Principal Stratification — a Goal or a Tool ? , 2011 .
[5] D. Rubin. Statistics and Causal Inference: Comment: Which Ifs Have Causal Answers , 1986 .
[6] R. Little. Missing-Data Adjustments in Large Surveys , 1988 .
[7] Michael R Elliott,et al. A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials , 2010, Biometrics.
[8] D. Rubin,et al. Principal Stratification in Causal Inference , 2002, Biometrics.
[9] Julian Wolfson,et al. Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials , 2010, Biometrics.
[10] Dean Follmann,et al. Augmented Designs to Assess Immune Response in Vaccine Trials , 2006, Biometrics.
[11] R. L. Prentice,et al. A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .
[12] D. Rubin. Randomization Analysis of Experimental Data: The Fisher Randomization Test Comment , 1980 .
[13] Ralf Bender,et al. Generating survival times to simulate Cox proportional hazards models , 2005, Statistics in medicine.
[14] T. VanderWeele. Simple relations between principal stratification and direct and indirect effects , 2008 .
[15] Peter B Gilbert,et al. ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL. , 2008, The annals of applied statistics.
[16] Judea Pearl,et al. Direct and Indirect Effects , 2001, UAI.
[17] J. Robins,et al. Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.
[18] Peter B Gilbert,et al. Comparing Biomarkers as Principal Surrogate Endpoints , 2011, Biometrics.
[19] Miguel A Hernán,et al. The hazards of hazard ratios. , 2010, Epidemiology.
[20] D. Basu. Randomization Analysis of Experimental Data: The Fisher Randomization Test , 1980 .
[21] D. Rubin. Direct and Indirect Causal Effects via Potential Outcomes * , 2004 .
[22] Tao Wang,et al. Multiple imputation methods for multivariate one-sided tests with missing data. , 2011, Biometrics.
[23] Ivan S. F. Chan,et al. Vaccine Clinical Trials , 2010 .
[24] Liqiu Jiang,et al. Multiple Imputation Approaches for the Analysis of Dichotomized Responses in Longitudinal Studies with Missing Data , 2010, Biometrics.
[25] Shein-Chung Chow. Encyclopedia of Biopharmaceutical Statistics , 2010 .
[26] Michael G Hudgens,et al. Evaluating Candidate Principal Surrogate Endpoints , 2008, Biometrics.
[27] Tom Greene,et al. Related Causal Frameworks for Surrogate Outcomes , 2009, Biometrics.
[28] Ivan S F Chan,et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.